1. Setyawati Y, Rahmawati Y, Widodo I, Ghozali A, Purnomosari D. The association between molecular subtypes of breast cancer with histological grade and lymph node metastases in Indonesian woman. Asian Pacific J Cancer Prev. 2018 May 1;19(5):1263–8.
2. Montemurro F, Martincich L, Sarotto I, Bertotto I, Ponzone R, Cellini L, et al. Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer. Eur Radiol. 2007 Jun;17(6):1490–7.
3. Elias SG, Adams A, Wisner DJ, Esserman LJ, Van’t Veer LJ, Mali WPTM, et al. Imaging features of HER2 overexpression in breast cancer: A systematic review and meta-analysis. Vol. 23, Cancer Epidemiology Biomarkers and Prevention. American Association for Cancer Research Inc.; 2014. p. 1464–83.
4. Boisserie-Lacroix M, Hurtevent-Labrot G, Ferron S, Lippa N, Bonnefoi H, Mac Grogan G. Correlation between imaging and molecular classification of breast cancers. Vol. 94, Diagnostic and Interventional Imaging. Elsevier Masson SAS; 2013. p. 1069–80.
5. Sutton EJ, Oh JH, Dashevsky BZ, Veeraraghavan H, Apte AP, Thakur SB, et al. Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay. J Magn Reson Imaging. 2015 Nov;42(5):1398–406.
6. Sohn YM, Han K, Seo M. Immunohistochemical Subtypes of Breast Cancer: Correlation with Clinicopathological and Radiological Factors. Iran J Radiol. 2016 Oct 1;13(4).
7. Prange A, Bokhof B, Polzer P, Tio J, Radke I, Heidinger O, et al. Higher Detection Rates of Biologically Aggressive Breast Cancers in Mammography Screening than in the Biennial Interval. RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgeb Verfahren. 2019;191(2):130–6.
8. Bae MS, Seo M, Kim KG, Park I-A, Moon WK. Quantitative MRI morphology of invasive breast cancer: correlation with immunohistochemical biomarkers and subtypes. Acta Radiol. 2015 Mar;56(3):269–75.